Clascoterone for Pilonidal Disease

Brief description of study

Determine the effect of clascoterone on clinical severity of PSD.
Analyze the influence of clascoterone in disease-specific quality of life.
Quantify the effect of clascoterone on surgical outcomes and cutaneous inflammation. 1. Medical photography with independent physician scores of PSD clinical severity at weeks 4, 8, and 12 on treatment 1. Patient reported quality of life scores with the Dermatology Life Quality Index at weeks 4, 8, and 12
Quantification of markers of inflammation in surgical specimens from PSD resection from those patients who come to surgery

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Medical Research
Age: - 99 Years
Gender: All

TBD

Updated on 10 Apr 2024. Study ID: 855173

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).